Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Updated boosters could go to the “worried well” who have good insurance rather than to those at highest risk.
After mishandling COVID-19 and monkeypox, the Centers for Disease Control and Prevention aims to change—with help from Mary Wakefield.
Updated Pfizer-BioNTech and Moderna bivalent boosters contain spike proteins from the original and BA.4 and BA.5 omicron variants.
Whether omicron coronavirus variants cause long COVID symptoms as often—and as severe—as previous variants is a matter of heated study.
The engineered protein vaccine was highly effective in a clinical trial but faced a long delay for authorization.
Fauci led the U.S. HIV research effort for nearly 40 years before becoming the nation’s leading COVID-19 medical advisor.
The update aims to help the public better protect themselves and understand their risk.
New studies offer evidence that an unexpected virus plays a role—but it needs a helper.
Antibody levels decrease substantially within three months after a booster, according to new clinical trial data.
The pandemic also disrupted medical care and had an indirect effect on other causes of death.
Randall N. Hyer, MD, PhD, will continue Blumberg Institute’s hepatitis B and liver cancer research in his new role as president.
Two drugs widely used to treat certain autoimmune diseases substantially improved clinical status and reduced deaths.
After a long wait, the FDA authorizes Pfizer and Moderna vaccines for children as young as 6 months old.
The virus can be transmitted via respiratory droplets at close range, but it does not spread through the air over longer distances.
Vaccines designed to produce a strong T cell response may help protect against current and future SARS-CoV-2 variants.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.